<DOC>
	<DOCNO>NCT01558908</DOCNO>
	<brief_summary>This 15 patient clinical trial assess safety feasibility use Endometrial Regenerative Cells ( ERC ) patient critical limb ischemia ( CLI ) eligible surgical catheter-based intervention . Three dos ERC examine . The hypothesis ERC administration well-tolerated possibly induce therapeutic benefit .</brief_summary>
	<brief_title>Phase I/II Trial Endometrial Regenerative Cells ( ERC ) Patients With Critical Limb Ischemia</brief_title>
	<detailed_description>The purpose trial determine safety intramuscularly derive menstrual mesenchymal stem cell ( otherwise know Endometrial Regenerative Cells , ERC ) patient critical limb ischemia ineligible revascularization . Safety define freedom treatment associate adverse event . Efficacy parameter comprise endpoint change ankle-brachial index , toe-brachial index , TcPO2 , ulcer healing , rest pain , quality life , reduction amputation . Patients receive 25 , 50 , 100 million menstrual derive mesenchymal stem cell ( Endometrial Regenerative Cells : ERC ) ten injection 2.5 , 5 , 10 million mesenchymal stem cell suspend volume 1 ml per injection . Injections space least 2 centimeter apart gastrocnemius muscle fail vascular perfusion area .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>1 . Nonpregnant patient critical limb ischemia , Rutherford IVV , manifest rest pain tissue loss , disable claudication , manifest exercise induce thigh calf pain impairs activity daily live , candidate surgical bypass angioplasty due unfavorable arterial anatomy absence adequate autogenous vein belowknee bypass . 2 . Patients 18 year age expect survival one year treatment . 3 . Unreconstructable arterial disease determine vascular surgeon participate study . Unreconstructable arterial disease define atherocclusive lesion within arterial tree extremity due extent morphology amenable surgical bypass PTCA stenting . 4 . Patients maximum 3 nonhealing 'flat ' surface 'transdermal ' ulcer Grades 12 , ulcer big 2 centimeter ( 2 ) 5 . Patients unfavorable anatomy medically unfit undergo bypass determine vascular surgeon participate study . 6 . Vascular imaging ( eg angiogram MRA ) determine vascular anatomy must conduct within 3 month study entry . 7 . Patients low/absent perfusion area gastrocnemius muscle 8 . Objective evidence severe peripheral arterial disease include ankle brachial index ( ABI ) less 0.55 , and/or rest toe brachial index ( TBI ) less 40 . 9 . Patients must competent give consent . 10 . No history malignant disease except nonmelanoma skin cancer , suspicious finding chest xray , mammography ( woman age 35 ) , Papanicolaou smear ( woman age 40 ) , normal fecal occult blood ( age 50 ) normal prostate specific antigen ( men age 45 ) . 11 . Patients must prothrombin Time ( PT ) 1214 second , partial thromboplastin time ( PTT ) 1828 second , platelet count &gt; 100,000/microliter 12 . Patients must white blood cell count ( 4.110.9x10 ( 3 ) cells/ÂµL ) 13 . Normal liver function test ( AST 8 20 U/L , ALT 8 20 U/L , total bilirubin 0.1 1.0 mg/dL ) 14 . Patients must male post menopausal woman . 1 . Patients evidence active proliferative retinopathy . 2 . Patients poorly control diabetes mellitus ( HbA1C &gt; 8.5 % ) . 3 . Patients renal insufficiency ( Creatinine &gt; 2.5 ) failure . 4 . Infection evidence WBC count &gt; 15,000 k/cumm and/or temperature &gt; 38C . 5 . Cellulitis afflict limb opinion investigator would require use antibiotic evidence osteomyelitis corroborate radiographic scintigraphic examination . 6 . Pregnant woman ( woman capable childbearing must negative pregnancy test ) 7 . Cognitively impaired adult 8 . Lower extremity venous disease pit edema . 9 . History organ transplant . 10 . Patients ulcer exudate , dry gangrene expose bone . 11 . Allergies betalactam antibiotic , amphotericin B , streptomycin 12 . Cardiovascular condition : Exercise limit angina ( Canadian Cardiovascular Society Class &gt; 3 Congestive heart failure ( New York Heart Association class &gt; 3 Unstable angina Acute ST elevation myocardial infarction ( MI ) within 1month Transient ischemic attack stroke within 1 month Severe valvular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>critical limb ischemia</keyword>
</DOC>